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Objectives
. The purpose of this study was to determine the
incidence of cardiologic abnormalities in Noonan syndrome.
Background. The incidence of cardiac abnormalities in Noonan
syndrome remains unknown, largely because of such difficulties as
assenlbllng a substantial cohort, ensuring a correct phenotypic
diagnosis and providing ticcurate definitions of the most frequent
abnormaltles--pulmonary stenosis and left ventricular hypertro-
phy.
Methods. A cohort of 145 patients was assembled, and before
cardlologic assessment two Independent geneticists scrutinized the
phenotype. The diagnosis was confirmed in 118 patients, and they
were studied by two-dimensional and Doppler echocardiography
.
Results. A dysplastic pulmonary valve was present in eight
patients (7%) and was associated with significant stenosis in six
(75%) of the eight . Significant stenosis was present in 22 (20 ) of
Previous reviews have suggested that the incidence of
Noonan syndrome is between I in 1,000 and in 1 in 2,000 of
the population (1,2), making it the most common syndrome
associated with congenital heart disease after Down syn-
drome. Cardiac abnormalities are often associated with
Noonan syndrome (3-6) ; however, the precise incidence is
uncertain . We therefore assembled a large cohort who had
careful assessment of the phenotype and studied them using
two-dimensional and Doppler echocardiography .
Methods
Study patients . An initial cohort of 145 patients with the
Noonan phenotype was studied. Patients were ascertained
with the help of the Noonan Syndrome Society, United
Kingdom, using a questionnaire designed to exclude cardio-
logic bias .
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110 patients without dysplasia. Left ventricular hypertrophy was
present in 29 patients (25%) without significant pulmonary steno-
sis. Localized anterior septa) hypertrophy was the most common
pattern in 12 (41%) of 29 patients . Diffuse hypertrophy Involving
the entire septum and the free wall was present in nine patients
(31%) and was severe (>1.7 cm) in five . Other abnormalities
included secundum atrial septal defects (10%) .
Conclusions. The high incidence of cardiac abnormalities
suggests that echocardiographic and Doppler evaluation of pa-
tients with tae Noonan phenotype Is important because it will aid
in genetic counseling and in the assessment of the natural history
of-and, ultimately, identification of the gene(s) responsible for-
Noonan syndrome.
(J Am Coll Cardiol 1993;22:118992)
The diagnosis of the Noonan phenotype was based on the
presence of the typical facial features, according to previ-
ously published criteria (2,7,8) .
Echocardiography. The assessment of hypertrophy was
performed using established methodology (9,10). Briefly, the
left ventricle was examined at end-diastole in the parasternal
short-axis view at the mitral valve and papillary muscle
levels and was then divided into quadrants for measurement .
Apical views were assessed in the anterior and posterior
positions. Systolic anterior motion of the mitral valve was
diagnosed from M mode recordings . The left ventricular
outflow tract gradient was assessed from the apical five-
chamber and suprasternal views using pulsed and continu-
ous wave Doppler echocardiography
. The right ventricle
was assessed for hypertrophy, again using established meth-
odology (11,12) . Measurements were taken of the right
ventricular free wall in the parasternal long-axis, parasternal
outlet, parasternal inlet and subcostal views .
The pulmonary valve was assessed using two-dimensional
echocardiography. Pulmonary valve dysplasia was diag-
nosed when the pulmonary valve diameter was less than the
normal mean (13) and there was asymmetric thickening of
the valve cusps with limited cusp movement (14,15) . Dopp-
ler studies of the pulmonary valve were performed in the
parasternal short-axis view using color, pulsed and steerable
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continuous wave Doppler ultrasound (16,17) . Right ventric-
ular outflow velocity was assessed by Doppler study before
pulmonary artery flow velocity to determine any significant
subvalvular obstruction (18) .
Pulmonary regurgitation was
assessed according to previously published methodology
(19) .
The diagnosis of left ventricular hypertrophy was made
when wall thickness exceeded 2 SD for an age-matched
control group . The definition of hypertrophy in Noonan
syndrome is complicated by the frequent association of
pulmonary stenosis
. which may result in septal hypertrophy
and mimic hypertrophic cardiomyopathy (20) .
Therefore any
patient with septal hypertrophy and pulmonary artery Dopp-
ler velocity >200 cm/s (arbitrarily taken as that velocity
below which right ventricular hypertrophy would be un-
likely) was excluded from calculations of
the incidence of
left ventricular hypertrophy. Right ventricular hypertrophy
was defined as a two-dimensional echocardiographie end-
diastolic wall thickness >2 SD from age-related normal
mean values .
Significant pulmonary stenosis was defined as a pulmo-
i i y artery Doppler velocity >300 cm/s, previously taken to
indicate significant stenosis (21), or previous intervention
(surgical valvotomy or balloon valvuloplasty) . Abnormal
pulmonary artery Doppler velocity was defined as a velocity
>2 SD from the mean value of the normal, control popula-
tion .
The control group was determined specifically for this
study. Analysis of echocardiograms was performed without
knowledge of the phenotypic diagnosis. Statistical analysis
was performed using a t test . Significance was assumed at
the 5% level . Results are expressed as mean value ± SD .
Results
Patient selection, From the 145 patients evaluated by the
clinical geneticists, 118 (65 male, 53 female patients aged I
week to 41 years [mean 10 years]) fulfilled the criteria for the
phenotypic diagnosis of Noonan syndrome .
Cardiac Abnormalities
Pulmonary stenosis, Dysplastic valves. The pulmonary
valve was dysplastic in eight patients (7%) and was defined
as significantly stenotic in six (75%) of the eight, Interven-
tion had been undertaken in three patients (two had surgical
valvotomy; one had balloon valvuloplasty) . A systolic ve-
locity <300 cm/5 with moderate pulmonary regurgitation
was revealed in both surgical cases . Conversely, a systolic
velocity >300 curls without regurgitation was found in the
child who had undergone balloon valvuloplasty . All Doppler
velocities in the patients who did not undergo surgery were
>2 SD from our normal mean value (180 cm/s).
lVondysplastic valves. Significant stenosis in nondysplas-
tic pulmonary valves was present in 22 (20%) of 110 patients .
Intervention was undertaken in 17 patients (15 had surgical
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Figure 1 . Body surface area versus (A) maximal left ventricular wall
thickness at end-diastole (LVmax) and (B) maximal right ventricular
wall thickness at end-diastole (RVmax) . Shaded areas = values
<95th percentile for normal subjects .
treatment; two had balloon valvuloplasty). Of these the
systolic gradient was >300 cmls in 1 patient (after surgery),
and pulmonary regurgitation was moderate in 10 and mild in
6. A pulmonary artery Doppler flow velocity >2 SD from our
normal trean value was found in 48 other patients (44%) ;
however, a murmur was audible in only 22 (46%) .
Ventricular hypertrophy. Wall thicknesses in n .lation to
that of age-matched control subjects are shown in Figure 1 .
Overall left ventricular hypertrophy was present in 29 (250)
of 118 patients, and in this group there was a positive
correlation with right ventricular wall thickness (r = 0 .7, p <
0.05) . Right ventricular hypertrophy was present in 20 (17%)
of 118 patients, and significant pulmonary stenosis was
present in 7 (35%) of the 20 and left ventricular hypertrophy
in 8 (40%) . Isolated septal hypertrophy was present in two
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Figure 2. Subaortic shelf in a 12-year old boy with Noonan syn-
drome. Two-dimensional echocardiogram in the parasternal long-
axis view, AO = aorta ; SS = subaortic shelf.
additional patients who had pulmonary artery Doppler flow
velocity >200 curls. However, they were not considered to
have left ventricular hypertrophy for the reasons defined
earlier (see Echocardiography) .
Maximal left ventricular wall thickness, in the 29 patients
with hypertrophy, was at the upper anterior septum in 26
patients, the free wall in 2 and the lower anterior septum in
1 . Hypertrophy involved the anterior septum in all 29
patients . In 12 patients (41%) it was confined to the anterior
septum, and in 5 of these 12 it was a localized upper septal
bulge (Fig . 2). In eight patients (28%) the posterior septum
was also involved . An additional nine patients (31%) had
diffuse hypertrophy involving the anteroseptal and poster-
oseptal regions and the free wall . Severe hypertrophy was
present in five of the latter nine patients, and maximal wall
thickness ranged from 1 .7 to 2 .7 cm (mean 2 .3 ± 0 .4) (Fig. 3) .
Systolic anterior :notion of the mitral
valve was present in all
five patients . It was complete, with septal and anterior leaflet
contact (22), in one patient who had a gradient of 64 mm Hg,
but the gradient was <36 mm Hg in the other four . None of
Figure 3 . Diffuse left ventricular hypertrophy in a 12-year old girl
with Noonan syndrome . Two-dimensional echocardiogram in the
parasternal short-axis view. AS = anterior septum
; FW = free wall ;
PS = posterior septum ; PW = posterior wall .
the patients with ventricular hypertrophy had an affected
first-degree relative on family screening, nor was there a
family history of sudden death in early adult life . In addition,
there was no history of syncope, and only one patient (an
infant) had evidence of cardiac failure .
Other Cardiac Abnormalities
Other cardiac abnormalities were common (Table 1) . All
but three of the septal defects had been corrected .
None of the three patients with aortic valve anomalies
had left ventricular hypertrophy. A supravalvular aortic
ridge has not been previously described in Noonan syn-
drome .
Discussion
To overcome the inherent difficulties of assessing the
incidence of cardiac problems in Noonan syndrome, this
study required a high level of genetic input . Cardiologic bias
was removed by not specifically drawing from cardiac clin-
ics. Furthermore, the large cohort enabled an accurate
assessment to be made
. Cardiac abnormalities were com-
mon, particularly pulmonary stenosis and ventricular hyper-
trophy. Some of the diagnoses reported in Noonan syn-
drome, howe% .;:, such as disorders of the aortic valve
sinuses and root (23,24), were not seen, in contrast to the
Marfan or Turner syndrome, where aortic valve and aortic
root problems are more common (25,26) .
'Pulmonary stenosis
. Only a minority of patients in our
study had the dysplastic valves thought typical of Noonan
syndrome. However, those with dysplastic valves were
more likely to need intervention and were less likely to have
a satisfactory result, which is consistent with previous
reports highlighting the difficulties of dilating dysplastic
valves (14,27,28). Thus, the outcome of
intervention is more
likely to reflect the presence or absence
of dysplasia rather
than Noonan syndrome as such
.
Ventricular hypertrophy.
It is uncertain whether the un-
explained left ventricular hypertrophy seen in 25% of pa-
tients in this study
represents hypertrophic cardiomyopathy .
We
recently reported histologic similarity between the hy-
pertrophy of Noonan syndrome and hypertrophic cardiomy-
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Table 1. Other Cardiac Abnormalities
Diagnosis
No. %
Secundum a:rial septal defect
12 9_8
Ventricular septal defect 3
0.8
Primum atrial septal defect
3 2 .5
Tetralogy of Fallot 1
0.8
Complete atrioventricular septa) defect 1
0.8
Aortic stenosis
1 0.8
Supravalvular aortic stenosis 1 0.8
Bicuspid aortic valve 1 0.8
Patent ductus arteriosus 1 0 .8
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apathy (29). The latter is a genetically heterogeneous dis-
ease, approximately 50% of patients having a missense
mutation in the gene encoding beta-cardiac heavy chain
myosin (30) . The echocardiographic morphology has been
welt described elsewhere (31) and, although similar, it ap-
pears: subtly different to that in patients with Noonan syn-
drome
. In this study hypertrophy was often confined to the
upper anterior septum and was only rarely severe and
dill , which is the converse of the appearance of hyper-
trophic cardiomyopathy. (The electrocardiogram was not
used, and although it can be helpful in diagnosing hypertro-
phy [32], it is less specific than echocardiography.) The
clinical course of the two diseases is also dissimilar . To our
knowledge, sudden death has not been reported in Noonan
syndrome, although it is common in hypertrophic cardiomy-
opathy (33,34) . Given the recent mapping of a gene for
familial hypertrophic cardiomyopathy to chromosome l4gt
(35), linkage studies in Noonan syndrome are feasible and
would be the final arbiter of whether the two conditions
share a common etiology and prognosis .
Coneluslom. The high incidence of cardiac abnormali .
ties, particularly left ventricular hypertrophy, pulmonary
stenosts, and secundum atria) septet defects, in the present
series of patients studied here confirms the importance of
cardiologic evaluation in the phenotypic assessment of pa-
tients with Noonan syndrome.
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